| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/29/2023 | LianBio | | Grant | Ordinary Shares | 325.9k | $0.00 | $0 | | 03/29/2023 |
| 01/20/2023 | LianBio | | Grant | Stock Option (Right to Buy) | 464.1k | $2.66 | $1.2M | | 01/20/2023 |
| 06/17/2022 | Olema Pharmaceuticals, Inc. | OLMA | Grant | Stock Option (Right to Buy) | 21.5k | $0.00 | $0 | | 06/17/2022 |
| 06/16/2022 | Olema Pharmaceuticals, Inc. | OLMA | Grant | Stock Option (Right to Buy) | 21.5k | $3.43 | $73.8k | | 06/16/2022 |
| 12/01/2021 | LianBio | | Grant | Stock Option (Right to Buy) | 6k | $16.00 | $95.9k | | 12/01/2021 |
| 10/31/2021 | LianBio | | Grant | Stock Option (Right to Buy) | 229.5k | $16.00 | $3.7M | | 10/31/2021 |
| 06/09/2021 | Olema Pharmaceuticals, Inc. | OLMA | Grant | Stock Option (right to buy) | 21.5k | $27.66 | $595.2k | | 06/09/2021 |
| 04/05/2021 | Olema Pharmaceuticals, Inc. | OLMA | Grant | Stock Option (Right to Buy) | 21.5k | $34.80 | $748.9k | | 04/05/2021 |
| 04/05/2021 | Olema Pharmaceuticals, Inc. | OLMA | Grant | Stock Option (Right to Buy) | 3.8k | $34.80 | $131.3k | | 04/05/2021 |
| 02/02/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 1.1k | $131.73 | $139.2k | | 02/01/2021 |
| 02/02/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 7.3k | $130.58 | $948.9k | | 02/01/2021 |
| 02/02/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 4.6k | $129.80 | $593.7k | | 02/01/2021 |
| 02/02/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 400 | $128.41 | $51.4k | | 02/01/2021 |
| 02/02/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 1000 | $127.58 | $127.6k | | 02/01/2021 |
| 02/02/2021 | Turning Point Therapeutics, Inc. | TPTX | Exercise | Stock Option (right to buy) | 14.3k | $54.03 | $772.5k | | 02/01/2021 |
| 02/01/2021 | Turning Point Therapeutics, Inc. | TPTX | Exercise | Stock Option (right to buy) | 15.7k | $54.03 | $848.4k | | 02/01/2021 |
| 02/01/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 200 | $126.07 | $25.2k | | 02/01/2021 |
| 02/01/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 2.1k | $124.60 | $267k | | 02/01/2021 |
| 02/01/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 8.6k | $123.70 | $1.1M | | 02/01/2021 |
| 02/01/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 4.8k | $122.94 | $588k | | 02/01/2021 |
| 01/06/2020 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 33k | $63.33 | $2.1M | | 01/06/2020 |
| 09/10/2019 | Turning Point Therapeutics, Inc. | TPTX | Purchase | Common Stock | 2.2k | $45.00 | $100k | | 09/10/2019 |
| 08/26/2019 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 312.4k | $54.03 | $16.9M | | 08/26/2019 |